Thursday, October 26, 2017 3:41:11 PM
GT Biopharma, Inc. - FORM 10-Q - EX-10.2 - LICENSE AGREEMENT WITH MULTICELL IMMUNOTHERAPEUTICS, INC. - August 11, 2017 http://www.getfilings.com/sec-filings/170811/GT-Biopharma-Inc_10-Q/oxis_ex102.htm#ixzz4we2yx3NC
15-12G Jan 13, 2017 http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11782012
8-K Sept 26, 2016 http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=11607008
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM